10x Genomics Consensus Price Target Increased by 13.66% to $60.62
Published . Updated .
The average one-year price target for 10x Genomics (NASDAQGS:TXG) (LSE:0A88) has been revised to $60.62 / share. This is an increase of 13.66% from the prior estimate of $53.33 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do n
Directly affected
- TXG 10x Genomics
Named in this report.
Indirectly affected
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for 10x Genomics (NASDAQGS:TXG) (LSE:0A88) has been revised to $60.62 / share. This is an increase of 13.66% from the prior estimate of $53.33 dated September 11, 2026. These figures represent aggregate an…
Source: Nasdaq Markets
10x Genomics (TXG) since this story, compared with the market
Since the first closing price after “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” 10x Genomics (TXG) is -28.58%. The S&P 500 fund (SPY) is -1.08% over the same days, a -27.50% difference versus the market.
Who gains and who loses around 10x Genomics (TXG)
Companies mentioned with this story
- TXG 10x Genomics
For “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” 10x Genomics (TXG) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names 10X GENOMICS INC in the headline; GA resolved that company to TXG
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
In “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
In “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence. Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
For “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
In “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDE Ishares Lifepath Target Date 2045 Etf Usd
In “10x Genomics Consensus Price Target Increased by 13.66% to $60.62,” Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “10x Genomics Consensus Price Target Increased by 13.66% to $60.62.” Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
10x Genomics (TXG)
“10x Genomics Consensus Price Target Increased by 13.66% to $60.62” (2 Oct 2026) reaches 10x Genomics (TXG) through this story.
The link for 10x Genomics (TXG) is this: The reported development directly names 10X GENOMICS INC in the headline; GA resolved that company to TXG
Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is here too. Its reason reads: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for 10x Genomics (TXG), and the dates in the story
DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99. FGSI traded between 20.20 and 20.62 across 5 sessions. The latest close on file is 20.27. TXG traded between 64.73 and 102.53 across 14 sessions. The latest close on file is 69.86.
What the saved facts support for 10x Genomics (TXG)
46 out of 100
“10x Genomics Consensus Price Target Increased by 13.66% to $60.62” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.